Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers: the extended family.

W D Hager, F C Messineo, A M Katz

    Advances in Internal Medicine
    |January 1, 1984
    PubMed
    Summary

    Beta-adrenergic blocking drugs inhibit sympathetic nervous system responses by blocking beta receptors. Their varying properties, like lipid solubility, allow for tailored cardiovascular disorder treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phylogeny and historical biogeography of neotropical catfishes Trichomycterus (Siluriformes: Trichomycteridae) from eastern Brazil.

    Molecular phylogenetics and evolution·2023
    Same author

    HEART FAILURE.

    A listing of research in the cardiovascular field·2014
    Same author

    Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.

    Genes, brain, and behavior·2012
    Same author

    Scientific insights from clinical studies of converting-enzyme inhibitors in the failing heart.

    Trends in cardiovascular medicine·2011
    Same author

    Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism.

    Neuroscience·2010
    Same author

    Femoral bone mineral density in patients with heart failure.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Sympathetic Nervous System

    Background:

    • Beta-adrenergic blocking drugs interfere with sympathetic nervous system responses by blocking beta receptors without activating adenylate cyclase.
    • This mechanism underpins their use in cardiovascular disorders where sympathetic tone is a contributing factor.

    Purpose of the Study:

    • To elucidate the mechanisms of beta-adrenergic blocking drugs.
    • To discuss how characteristics like lipid solubility and receptor selectivity influence their effects.
    • To highlight the potential for developing more targeted beta blockers.

    Main Methods:

    • Review of existing literature on beta-adrenergic blocking drugs.
    • Analysis of the pharmacodynamics and pharmacologic effects based on drug properties.
    • Discussion of the role of the sympathetic nervous system in cardiovascular disease pathogenesis.

    Main Results:

    • Beta blockers occupy beta receptors, inhibiting sympathetic responses.
    • Lipid solubility, receptor selectivity, and intrinsic sympathomimetic activity modulate drug effects.
    • Understanding sympathetic nervous system's role is key to developing improved beta blockers.

    Conclusions:

    • Beta-adrenergic blocking drugs are crucial for managing cardiovascular conditions linked to sympathetic overactivity.
    • Tailoring treatments based on specific drug profiles (e.g., selectivity, solubility) can optimize therapeutic outcomes.
    • Further research into the sympathetic nervous system may lead to novel beta blockers with enhanced efficacy and safety profiles.

    Related Experiment Videos